APPLICATION
NDA211950
TYPE
NDA
ORIGINAL APPROVAL
2021-10-22
LATEST ACTION
2025-05-22
ROUTE
OPHTHALMIC, INJECTION
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Prescription
Products
XIPERE · ReferencePrescription
TRIAMCINOLONE ACETONIDE 40MG/ML · SUSPENSION · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.